Biological Weapons and Warfare

The threat of biological weapons and warfare poses particular challenges to government officials charged with devising immediate and longer-term emergency response plans. RAND has developed exercises to train public health agencies to respond to bioterrorism; examined the longer-term psychological consequences of bioterrorism; and created guidelines to improve individual preparedness for chemical, radiological, nuclear, and biological attacks.

Research conducted by: RAND National Security Research Division; RAND Project AIR FORCE; RAND Arroyo Center; RAND Health

Research Briefs (4)

The Department of Defense Can Improve Its Response to and Management of Anthrax Incidents — Apr 13, 2009

Assesses the Department of Defense (DoD) response to three potential anthrax-related incidents at DoD facilities in March 2005 and recommends ways that DoD can improve its incident-response capabilities.

Examining Possible Causes of Gulf War Illness: RAND Policy Investigations and Reviews of the Scientific Literature — Nov 25, 2005

This research brief outlines assistance that RAND provided to the OSAGWI in investigating the health effects of eight areas of possible causes of illness: infectious diseases, pyridostigmine bromide, immunizations, wartime stress, chemical and biological warfare agents, oil well fires, depleted uranium, and pesticides.

An Individual’s Strategy for Responding to Chemical, Radiological, Nuclear, and Biological Terrorist Attacks — Jan 1, 2003

This research brief describes work documented in Individual Preparedness and Response to Chemical, Radiological, Nuclear, and Biological Terrorist Attacks (MR-1731-SF).

Waiving Informed Consent: Military Use of Non-FDA-Approved Drugs in Combat — Jan 1, 2000

The 1991 Gulf War raised a number of ethical and policy questions regarding the use of investigational drugs to defend against chemical and biological warfare (CW/BW) agents.

My RAND ?

Saved Items

Recommended